311 related articles for article (PubMed ID: 24340021)
1. The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling.
Meng J; Zhou P; Liu Y; Liu F; Yi X; Liu S; Holtappels G; Bachert C; Zhang N
PLoS One; 2013; 8(12):e82373. PubMed ID: 24340021
[TBL] [Abstract][Full Text] [Related]
2. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients.
Tengroth L; Arebro J; Kumlien Georén S; Winqvist O; Cardell LO
PLoS One; 2014; 9(8):e105618. PubMed ID: 25133733
[TBL] [Abstract][Full Text] [Related]
3. Can the AGE/RAGE/ERK signalling pathway and the epithelial-to-mesenchymal transition interact in the pathogenesis of chronic rhinosinusitis with nasal polyps?
Vetuschi A; Pompili S; Di Marco GP; Calvaruso F; Iacomino E; Angelosante L; Festuccia C; Colapietro A; Sferra R
Eur J Histochem; 2020 Jan; 64(1):. PubMed ID: 31988531
[TBL] [Abstract][Full Text] [Related]
4. Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and Toll-like receptor 3 ligation.
Yamin M; Holbrook EH; Gray ST; Busaba NY; Lovett B; Hamilos DL
Int Forum Allergy Rhinol; 2015 Jul; 5(7):573-82. PubMed ID: 25914020
[TBL] [Abstract][Full Text] [Related]
5. [Features of epithelial-to-mesenchymal transition in nasal polyposis].
Li J; Zhang Y; Zhang L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Mar; 51(3):174-8. PubMed ID: 27033570
[TBL] [Abstract][Full Text] [Related]
6. Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis.
Wang X; Zhao C; Ji W; Xu Y; Guo H
Int J Clin Exp Pathol; 2015; 8(2):1199-212. PubMed ID: 25973005
[TBL] [Abstract][Full Text] [Related]
7. H3N2 influenza virus infection enhances oncostatin M expression in human nasal epithelium.
Tian T; Zi X; Peng Y; Wang Z; Hong H; Yan Y; Guan W; Tan KS; Liu J; Ong HH; Kang X; Yu J; Ong YK; Thong KT; Shi L; Ye J; Wang DY
Exp Cell Res; 2018 Oct; 371(2):322-329. PubMed ID: 30142324
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21.
Li X; Li C; Zhu G; Yuan W; Xiao ZA
Int Arch Allergy Immunol; 2019; 179(4):304-319. PubMed ID: 30982052
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1.
Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A
Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394
[TBL] [Abstract][Full Text] [Related]
10. BMP-2 and IL-1β as Markers of Nasal Mucosa Inflammation in Rhinosinusitis with Nasal Polyps.
Matveeva NY; Pavlush DG; Kalinichenko SG
Bull Exp Biol Med; 2023 Feb; 174(4):455-459. PubMed ID: 36913089
[TBL] [Abstract][Full Text] [Related]
11. Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps.
Jiao J; Duan S; Meng N; Li Y; Fan E; Zhang L
Clin Exp Allergy; 2016 Mar; 46(3):449-60. PubMed ID: 26399381
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus enterotoxin B disrupts nasal epithelial barrier integrity.
Martens K; Seys SF; Alpizar YA; Schrijvers R; Bullens DMA; Breynaert C; Lebeer S; Steelant B
Clin Exp Allergy; 2021 Jan; 51(1):87-98. PubMed ID: 33090566
[TBL] [Abstract][Full Text] [Related]
13. Nasal polyposis: from cytokines to growth.
Bachert C; Gevaert P; Holtappels G; Cuvelier C; van Cauwenberge P
Am J Rhinol; 2000; 14(5):279-90. PubMed ID: 11068652
[TBL] [Abstract][Full Text] [Related]
14. Altered Th17/Treg Ratio in Nasal Polyps With Distinct Cytokine Profile: Association With Patterns of Inflammation and Mucosal Remodeling.
Wu D; Wang J; Zhang M
Medicine (Baltimore); 2016 Mar; 95(10):e2998. PubMed ID: 26962811
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-α receptor expression correlates with mucosal changes and biofilm presence in chronic rhinosinusitis with nasal polyposis.
Karosi T; Csomor P; Sziklai I
Laryngoscope; 2012 Mar; 122(3):504-10. PubMed ID: 22231697
[TBL] [Abstract][Full Text] [Related]
16. [Significance and expression of transforming growth factor beta in human nasal polyp tissue].
Wang Q; Wang T; Chen F; Li Z; Xin X
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Jun; 36(3):199-202. PubMed ID: 12761924
[TBL] [Abstract][Full Text] [Related]
17. The role of B cell Activating Factor (BAFF) expression on pathogenesis of nasal polyp in chronic rhinosinusitis with nasal polyposis.
Yoon YH; Jin J; Kwon KR; Kim SH; Rha KS; Kim YM
Rhinology; 2014 Dec; 52(4):390-6. PubMed ID: 25479221
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps.
Bachert C; Hicks A; Gane S; Peters AT; Gevaert P; Nash S; Horowitz JE; Sacks H; Jacob-Nara JA
Front Immunol; 2024; 15():1356298. PubMed ID: 38690264
[TBL] [Abstract][Full Text] [Related]
19. Differences in the distribution of CD20, CD3, CD34 and CD45RO in nasal mucosa and polyps from patients with chronic rhinosinusitis.
Mitroi M; Albulescu D; Capitanescu A; Docea AO; Musat G; Mitroi G; Zlatian O; Tsatsakis A; Tzanakakis G; Spandidos DA; Calina D
Mol Med Rep; 2019 Apr; 19(4):2792-2800. PubMed ID: 30720103
[TBL] [Abstract][Full Text] [Related]
20. Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps.
Linke R; Pries R; Könnecke M; Bruchhage KL; Böscke R; Gebhard M; Wollenberg B
Int Arch Allergy Immunol; 2013; 162(4):290-8. PubMed ID: 24157808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
